TOTVS S.A. TOTS3
BMFBOVESPA · Brazil · Technology Services
BRL 35.17+1.74 (+5.20%)
Market open· · BRL · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · BRL · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
TORONTO & RIO DE JANEIRO, August 26, 2026--Sofis, a Brazilian healthcare software provider specializing in hemotherapy and cell therapy solutions, announced the appointment of Rafael Fraga as incoming Chief Executive Officer. Arcadea Group acquired a majority stake in Sofis earlier in 2026. Fraga joins founder Reynaldo Mendes, who will stay on in a leadership role with the business and transfer full responsibilities to Fraga over the coming months.
Totvs SA (TTVSY) reports robust financial performance with significant SaaS growth and successful Linx integration, despite challenges in the credit market.
The updated analyst view on TOTVS centers on a consolidated fair value move from R$51.75 to R$50.45 and a specific price target of R$47. Analysts link this recalibration to a more cautious but still constructive stance, with the R$47 level described as consistent with fair value work while allowing for differing opinions. Read on to see how this evolving price target narrative might influence the way you track TOTVS from here. Stay updated as the Fair Value for TOTVS shifts by adding it to...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.